Outcomes after Total Knee Arthroplasty for post-traumatic arthritis.

Journal Article (Journal Article)

INTRODUCTION: Total Knee Arthroplasty (TKA) is an important treatment for posttraumatic arthritis (PTA), but evidence on outcomes is sparse. The purpose of this study was to evaluate the impact of PTA versus primary osteoarthritis (OA) on postoperative outcomes after TKA. METHODS: We queried the entire Medicare database from 2005 to 2012. International Classification of Diseases, 9th revision and Current Procedural Terminology codes were used to identify the procedure, indication, and complications. Patients with minimum two-years follow-up were selected. Odds ratios (ORs), confidence intervals, and p-values (p) were calculated. RESULTS: For PTA, 3509 patients had TKA. For OA, 257,611 patients with TKA served as controls. The average Charlson Comorbidity Index for both groups was five. PTA patients were younger; only eight out of 29 Elixhauser comorbidities were higher. PTA patients had higher incidence of periprosthetic infection (OR 1.72, p<0.001), cellulitis or seroma (OR 1.19, p<0.001), knee wound complications (OR 1.80, p<0.001), TKA revision (OR 1.23, p=0.01), and arthrotomy/incision and drainage (OR 1.55, p<0.001). Blood transfusion rate was lower in PTA patients. There were no significant differences in bleeding complications, prosthetic dislocation, broken prostheses, periprosthetic fracture, osteolysis and polywear, neurovascular injury, and extensor mechanism rupture. DISCUSSION AND CONCLUSION: This study represents, to our knowledge, TKA outcomes in the largest cohort of PTA patients to date. Our findings indicate that these patients are at higher risk for many, but not all, postoperative surgical complications despite being as healthy as patients receiving TKA for primary OA.

Full Text

Duke Authors

Cited Authors

  • Bala, A; Penrose, CT; Seyler, TM; Mather, RC; Wellman, SS; Bolognesi, MP

Published Date

  • December 2015

Published In

Volume / Issue

  • 22 / 6

Start / End Page

  • 630 - 639

PubMed ID

  • 26526636

Electronic International Standard Serial Number (EISSN)

  • 1873-5800

Digital Object Identifier (DOI)

  • 10.1016/j.knee.2015.10.004


  • eng

Conference Location

  • Netherlands